关键词: font-size:medium, ">儿童用药；药品研发；儿科临床试验；激励政策

Abstract: By comparing the current situation and incentive policies of pediatric drug research and development in China with those developed countries in western， this paper analyzes the gap between the current situation of pediatric drug research and development in China and that in Europe and the United States， and looks for the shortcomings of the incentive policies of pediatric drug research and development in China， and draws on the experience of Europe and the United States to put forward feasible suggestions for pediatric drug research and development in China in the future. Compared with Europe and the United States， there are obvious gaps in drug clinical trials， children ′s medication information， new indications， children ′s medication clinical trial data and other aspects. This paper suggests that China should improve the regulatory agencies， clinical trials， R&D data， incentive policy system and patent protection of pediatric drug use， and formulate more scientific and comprehensive incentive policies for pediatric drug R&D.

Key words: font-size:medium, ">Pediatric drugs； Research and development of the drugs； Pediatric clinical trials； Incentive policy